The voice of medical practices in Washington

Advocacy Letter

May 30, 2023: MGMA submits testimony to House Committee on Ways & Means for hearing on healthcare price transparency

Advocacy Letter

May 26, 2023: MGMA and coalition partners thank Senate subcommittee for holding hearing examining delays and denials in Medicare Advantage

Advocacy Letter

May 22, 2023: MGMA and coalition partners express support for S. 1302, the Resident Physician Shortage Reduction Act of 2023

Advocacy Letter

May 22, 2023: MGMA and partner organizations urge Congress to pass H.R. 2377, the Saving Access to Laboratory Services Act (SALSA)

Advocacy Letter

May 17, 2023: MGMA submits testimony for Senate Committee on Homeland Security and Governmental Affairs subcommittee hearing on healthcare delays and denials in Medicare Advantage

Advocacy Letter

May 8, 2023: MGMA and 171 other stakeholders urge UHC to not implement its new GI endoscopy prior authorization program

Advocacy Letter

May 8, 2023: MGMA and coalition partners express support for legislation to expand the physician workforce

Advocacy Letter

May 3, 2023: MGMA and other stakeholder organizations send letter in support of H.R. 2474 to ensure Medicare physician payments keep up with inflation

Press Statement

May 3, 2023: MGMA statement on latest data on prior authorization within the Medicare Advantage program

Advocacy Letter

April 25, 2023: MGMA and other healthcare stakeholders endorse the Chronic Care Management Improvement Act of 2023 to ensure that more chronically ill Medicare patients receive access to high-quality care

Advocacy Letter

April 24, 2023: MGMA and coalition partners urge Congress to urge Congress to repeal Section 510 in the Labor-HHS appropriations bill regarding Patient ID

Advocacy Letter

April 24, 2023: MGMA and coalition partners urge Congress to assign funds to ONC for improving and supporting patient matching efforts

Advocacy Letter

April 21, 2023: MGMA comments on CMS' HIPAA attachment standards proposed rule

Advocacy Letter

April 19, 2023: MGMA and partner organizations send letter in support of H.R. 2474 to ensure Medicare physician payments keep up with inflation

Advocacy Letter

April 18, 2023: MGMA and partner healthcare stakeholders urge Cigna to rescind latest modifier 25 policy

Press Statement

April 6, 2023: MGMA statement on the Strengthening Medicare for Patients and Providers Act (H.R. 2474)

Press Statement

April 5, 2023: MGMA statement on prior authorization policies in the 2024 MA and Part D final rule

Advocacy Letter

March 31, 2023: MGMA and stakeholder partners urge DEA to modify telehealth prescribing rules for mental health treatment

Advocacy Letter

March 21, 2023: MGMA and partner healthcare organizations write Congress in support of legislation that strengthens the healthcare workforce

Advocacy Letter

March 20, 2023: MGMA response to Senate HELP RFI on healthcare workforce shortage

Advocacy Letter

March 15, 2023: MGMA and partner healthcare organizations share feedback on MedPAC's March 2023 report

Press Statement

March 15, 2023: MGMA statement on March 2023 MedPAC report

Advocacy Letter

March 13, 2023: MGMA and coalition partners comment on prior authorization and interoperability proposed rule

Advocacy Letter

March 13, 2023: MGMA comments on interoperability and prior authorization proposed rule

Advocacy Letter

March 2, 2023: MGMA and coalition partners share recommendations on MIPS Value Pathways (MVPs) with CMS

Advocacy Letter

March 2, 2023: MGMA comments to CMS on CY 2024 Advance Notice

Advocacy Letter

February 13, 2023: MGMA and Regulatory Relief Coalition partners provide feedback on MA Part C and Part D proposed rule

Advocacy Letter

February 13, 2023: MGMA and other leading healthcare organizations send CMS letter of support for prior authorization reforms in Medicare Part C and Part D proposed rule

Advocacy Letter

February 13, 2023: MGMA and coalition partners send Congress recommendations to promote value-based patient care in Medicare

Advocacy Letter

February 13, 2023: MGMA and coalition partners urge CMS to reinstate the step therapy prohibition in Medicare Advantage plans for Part B drugs

Advocacy Letter

February 10, 2023: MGMA comments on prior authorization policies in the 2024 MA and Part D proposed rule

Advocacy Letter

January 30, 2023: MGMA response to RFI on the CONNECT for Health Act

Advocacy Letter

January 23, 2023: MGMA and over 100 coalition partners urge Congress to reform the Medicare payment system and explore long-term payment solutions

Press Statement

January 18, 2023: MGMA statement on 2023 advocacy priorities

Press Statement

December 20, 2022: MGMA statement on Medicare cut provisions included in omnibus draft

Press Statement

December 6, 2022: MGMA statement on CMS’ electronic prior authorization proposed rule

Advocacy Letter

December 5, 2022: MGMA and other healthcare organizations urge Congressional action to prevent 4.5% cut to Medicare payment rates

Advocacy Letter

December 1, 2022: MGMA and coalition partners urge Congress to include prior authorization in a year-end legislative package

Advocacy Letter

November 21, 2022: MGMA and other radiation oncology stakeholders urge Congress to prevent significant Medicare payment cuts to radiation therapy services

Advocacy Letter

November 15, 2022: MGMA provides recommendations surrounding advanced explanation of benefits (AEOB) and good faith estimate (GFE) requirements

Advocacy Letter

November 14, 2022: MGMA legislative recommendations to support group practices in 2023

Press Statement

November 1, 2022: MGMA statement on CMS' final 2023 Medicare Physician Fee Schedule

Press Statement

October 11, 2022: Medical Practices Report Significant Increase in Regulatory Burden

Advocacy Letter

October 3, 2022: MGMA submits comments on proposed rule amending regulations under Section 1557 of the Affordable Care Act

Advocacy Letter

September 30, 2022: MGMA and leading health organizations express support for legislation to mitigate Medicare reimbursement cuts

Advocacy Letter

September 28, 2022: MGMA and over 800 other organizations ask Congress to extend the Medicare APM incentive payments

Advocacy Letter

September 27, 2022: MGMA and partner organizations urge CMS to create appropriate policies for future requirements under the No Surprises Act

Advocacy Letter

September 26, 2022: MGMA and and other health IT stakeholders urge HHS to postpone upcoming information blocking compliance deadlines

Press Statement

September 21, 2022: MGMA statement on Medicare payment reduction findings

Press Statement

September 14, 2022: MGMA statement on House passage of the Improving Seniors' Timely Access to Care Act

Advocacy Letter

September 13, 2022: MGMA and partner organizations urge Senate leadership to extend telehealth flexibilities

Advocacy Letter

September 13, 2022: MGMA and coalition partners provide comment to CMS on the 2023 OPPS proposed rule

Press Statement

September 13, 2022: MGMA statement on the Supporting Medicare Providers Act of 2022

Advocacy Letter

September 12, 2022: MGMA legislative recommendations to support group practices in 2023

Advocacy Letter

September 8, 2022: MGMA and other leading healthcare organizations urge Congress to protect patient access to clinical laboratory services

Advocacy Letter

September 6, 2022: MGMA provides comprehensive comments on 2023 Medicare Physician Fee Schedule proposals

Advocacy Letter

September 1, 2022: MGMA and partner organizations submit comments supporting value-based care in the 2023 proposed Physician Fee Schedule

Advocacy Letter

August 31, 2022: MGMA and partner organizations request information from CMS regarding Medicare Advantage

Advocacy Letter

August 31, 2022: MGMA provides recommendations to improve Medicare Advantage

Advocacy Letter

August 18, 2022: MGMA and partner organizations request additional clarity and guidance surrounding information blocking regulations

Advocacy Letter

August 11, 2022: MGMA urges HHS to provide 90-day notice prior to end of COVID-19 PHE

Advocacy Letter

August 2, 2022: MGMA urges appropriate implementation timeline for No Surprises Act enforcement

Advocacy Letter

July 27, 2022: MGMA and partner organizations urge Congress to take action to mitigate pending Medicare cuts

Press Statement

July 27, 2022: MGMA statement on the Improving Seniors' Timely Access to Care Act

Advocacy Letter

July 20, 2022: MGMA urges swift passage of the GOLD CARD Act of 2022

Advocacy Letter

July 18, 2022: MGMA and partner organizations urge Congress for increased Medicare support for GME

Press Statement

July 7, 2022: MGMA statement on CMS' proposed 2023 Medicare Physician Fee Schedule

Advocacy Letter

June 13, 2022: MGMA and partner organizations urge HHS for additional education opportunities on information blocking laws and request warning communications prior to disincentives

Advocacy Letter

June 6, 2022: MGMA provides recommendations to HHS on certain provisions from the HITECH Act

Advocacy Letter

June 1, 2022: MGMA and partner organizations urge CMS to reinstate step therapy prohibition in Medicare Advantage for Part B drugs

Advocacy Letter

May 27, 2022: MGMA and partner organizations urge Congress to pass legislation to advance equity and address the social determinants of health

Advocacy Letter

May 22, 2022: MGMA and leading health organizations urge Congress to further refine VALID Act

Advocacy Letter

May 18, 2022: MGMA and other leading healthcare organizations write to CMS with concerns over AUC Program mandate

Advocacy Letter

May 18, 2022: MGMA provides recommendations to improve the federal Independent Dispute Resolution (IDR) Portal

Advocacy Letter

May 11, 2022: MGMA to HHS: Extend COVID-19 Public Health Emergency

Advocacy Letter

May 4, 2022: MGMA and coalition organizations urge Congress to repeal Section 510 in the Labor-HHS appropriations bill regarding Patient ID

Advocacy Letter

April 27, 2022: MGMA and other healthcare organizations urge Congress to replenish COVID-19 Uninsured Program

Advocacy Letter

April 21, 2022: MGMA sends letter to OSHA outlining concerns over permanent healthcare mandate

Advocacy Letter

April 15, 2022: MGMA to PTAC: Considerations to support practice participation in value-based care models

Advocacy Letter

April 4, 2022: MGMA to CMS: Standardization and additional guidance necessary under the No Surprises Act

Advocacy Letter

March 31, 2022: MGMA and other leading healthcare organizations urge HRSA to exercise flexibility for Period 1 reporting

Advocacy Letter

March 30, 2022: MGMA to CMS: Improvements in value-based care to support health equity

Advocacy Letter

March 29, 2022: MGMA and leading medical organizations urge CMS to propose an alternative strategy for billing split or shared visits

Advocacy Letter

March 23, 2022: MGMA submits comments to ONC on electronic prior authorization standards, implementation, and certification criteria

Press Statement

March 15, 2022: MGMA Statement on MedPAC's March 2022 Report to Congress

Advocacy Letter

March 10, 2022: MGMA and 110 other national healthcare stakeholders urge Congress to extend the Hospital at Home waiver beyond the pandemic

Advocacy Letter

March 7, 2022: MGMA and coalition partners respond to Medicare Advantage RFI related to prior authorization

Advocacy Letter

March 7, 2022: MGMA submits comments to CMS to improve the uninsured and self-pay GFE requirements

Press Statement

March 3, 2022: MGMA Statement on Latest Prior Authorization Data

Advocacy Letter

February 28, 2022: MGMA and partner organizations urge Congress to extend 2% Medicare sequester until the end of the public health emergency

Advocacy Letter

February 25, 2022: MGMA and leading healthcare organizations urge Congress to collaborate with providers on potential Medicare payment reforms

Advocacy Letter

February 23, 2022: MGMA and partner organizations urge Congress to allow sufficient time to evaluate legislation to change regulations for laboratory developed tests independently

Advocacy Letter

February 14, 2022: MGMA and hundreds of healthcare organizations urge HHS to fix, not end, the Direct Contracting Model

Advocacy Letter

February 11, 2022: MGMA and other health organizations urge Congress to modify radiation oncology policies

Advocacy Letter

February 2, 2022: MGMA and leading healthcare organizations support value-based payment arrangements and APMs as a means to prolong solvency of Medicare trust fund

Press Statement

February 2, 2022: MGMA Statement on the Introduction of the SURS Extension Act

Advocacy Letter

January 31, 2022: MGMA and several hundred other organizations ask Congress to extend telehealth flexibilities

Advocacy Letter

January 28, 2022: MGMA sends Congress priorities for inclusion in funding legislation

Advocacy Letter

January 26, 2022: MGMA and other leading organizations voice concerns over United Healthcare’s Designated Diagnostic Provider program

Advocacy Letter

January 26, 2022: MGMA urges HHS to delay uninsured or self-pay good faith estimate requirements

Advocacy Letter

January 12, 2022: MGMA to HHS: Renew COVID-19 PHE

Advocacy Letter

January 6, 2022: MGMA and other leading organizations urge Administration to reevaluate FHIR API policies

Press Statement

January 6, 2022: MGMA Statement on Health Care Value Week

Press Release

January 6, 2022: MGMA Statement on Health Care Value Week

Advocacy Letter

January 5, 2022: MGMA and other leading organizations urge Administration to reevaluate FHIR API policies

Press Statement

December 9, 2021: MGMA Statement on Passage of Legislation Largely Averting Cuts to Medicare

Advocacy Letter

December 6, 2021: MGMA submits comments on Requirements Related to Surprise Billing; Part II

Advocacy Letter

December 6, 2021: MGMA concerns over Medicare cuts that threaten patient access to care

Press Statement

December 2, 2021: MGMA Statement on Congress's Failure to Avert Medicare Cuts

Advocacy Letter

November 30, 2021: MGMA and other leading health organizations urge Congress to prevent cuts to physician labs in 2022

Advocacy Letter

November 29, 2021: MGMA and other leading organizations urge Congress to prevent cuts to Medicare reimbursement in 2022

Advocacy Letter

November 23, 2021: MGMA and other leading health organizations urge CMS to reinstate step therapy prohibition in MA plans for Part B drugs

Press Statement

November 19, 2021: MGMA statement in support of legislation to avert cuts to Medicare payments in CY 2022

Advocacy Letter

November 19, 2021: MGMA and leading health organizations urge Congress to support radiation oncology by preventing cuts in CY 2022

Advocacy Letter

November 19, 2021: MGMA and other health organizations urge Congress to extend the QPP-SURS program

Advocacy Letter

November 17, 2021: MGMA and leading health organizations urge HHS to revise QPA element of IDR process

Press Statement

November 17, 2021: MGMA Statement on the Introduction of Cures 2.0

Advocacy Letter

November 15, 2021: MGMA urges House Ways and Means Committee to hold hearing on Medicare payment cuts

Press Statement

October 20, 2021: MGMA Statement on Introduction of Prior Auth. Reform Bill in Senate

Advocacy Letter

October 14, 2021: MGMA and leading health organizations urge CMS to allow benchmarking flexibility for MSSP ACOs

Advocacy Letter

October 14, 2021: MGMA and coalition of national health organizations urge CMS to clarify and affirm provider right to EFT payments

Advocacy Letter

October 13, 2021: MGMA and other leading health organizations urge Administration to leverage physician practices in COVID-19 vaccine rollout

Advocacy Letter

September 13, 2021: MGMA shares comprehensive comments on 2022 Medicare Physician Fee Schedule proposals

Advocacy Letter

September 9, 2021: MGMA and other national health organizations urge HHS to advance health equity and value through APMs

Advocacy Letter

September 1, 2021: MGMA and other national healthcare organizations urge Congress to increase Medicare support for GME

Advocacy Letter

September 3, 2021: MGMA submits comments to HHS on requirements related to surprise medical billing

Advocacy Letter

August 2, 2021: MGMA and federation of healthcare organizations urge NCVHS to continue support for CPT

Advocacy Letter

August 24, 2021: MGMA urges HHS to extend PRF reporting deadline

Advocacy Letter

August 24, 2021: MGMA and leading health organizations urge inclusion of Value in Health Care Act in reconciliation package

Advocacy Letter

August 20, 2021: MGMA submits comments to OSHA in response to healthcare ETS

Press Statement

August 13, 2021: MGMA calls for prohibition on insurers charging EFT fees

Advocacy Letter

August 11, 2021: MGMA calls on CMS to use its authority to prohibit EFT fees

Press Statement

August 4, 2021: MGMA statement in support of medical group COVID-19 vaccination policies

Advocacy Letter

July 30, 2021: MGMA submits comments to NCVHS on development, adoption, and implementation of new healthcare standards

Advocacy Letter

July 29, 2021: MGMA and other leading healthcare organizations endorse the Seniors’ Chronic Care Management Improvement Act of 2021

Advocacy Letter

July 26, 2021: MGMA and other leading healthcare organizations outline priorities for Medicare telehealth reform

Advocacy Letter

July 23, 2021: MGMA and other national health organizations call on Congress to maintain the 3.75% increase to Medicare conversion factor

Advocacy Letter

July 20, 2021: MGMA and other national health stakeholder groups urge support for the Value in Health Care Act

Press Statement

July 13, 2021: MGMA statement in response to CMS' proposed 2022 physician fee schedule rule

Advocacy Letter

June 30, 2021: MGMA sends letter requesting DOL rescind, delay OSHA healthcare ETS

Advocacy Letter

June 28, 2021: MGMA and other leading healthcare organizations recommend distribution methodology for new GME slots

Advocacy Letter

June 15, 2021: MGMA and coalition of national healthcare groups express support for the Accountable Care In Rural America Act

Advocacy Letter

May 27, 2021: MGMA welcomes new CMS Administrator Chiquita Brooks-LaSure

Advocacy Letter

May 25, 2021: MGMA and other leading healthcare organizations offer recommendations to new CMMI Director to improve APMs

Press Statement

May 20, 2021: New MGMA Poll Shows Prior Authorization on the Rise Despite COVID-19 Pandemic

Advocacy Letter

May 18, 2021: MGMA and other leading health care organizations urge Congress to support physician workforce in upcoming infrastructure package

Advocacy Letter

May 13, 2021: MGMA urges modifications to the Provider Relief Fund

Press Statement

May 13, 2021: MGMA statement on House of Representatives’ proposal to address Medicare Advantage plan prior authorization abuses

Press Statement

May 5, 2021: MGMA statement and comment letter to HHS/OCR Re: proposed modifications to the HIPAA Privacy Rule

Advocacy Letter

May 4, 2021: MGMA and other leading associations ask HHS to delay mandatory MSSP quality reporting changes

Advocacy Letter

May 4, 2021: MGMA submits comments in response to proposed modifications to HIPAA Privacy Rule

Advocacy Letter

April 27, 2021: MGMA and other leading healthcare organizations urge Congress to address FY 2022 Medicare cuts in infrastructure package

Advocacy Letter

April 27, 2021: MGMA submits comments to Ways & Means Health Subcommittee regarding the future of telehealth

April 22, 2021: MGMA and other health organizations urge CMS to reinstate step therapy prohibition on Part B drugs in MA plans

Advocacy Letter

April 19, 2021: MGMA and coalition of national health organizations support legislation to remove negative tax implications from PRF assistance

Advocacy Letter

April 12, 2021: MGMA and coalition of healthcare organizations urge HHS to extend Next Gen ACOs through 2022

Advocacy Statement

April 13, 2021: MGMA applauds passage of legislation that extends the 2% Medicare sequester moratorium

Advocacy Letter

April 13, 2021: MGMA and coalition of national health leaders urge CMS to release MIPS cost measure benchmark data

Advocacy Letter

April 1, 2021: MGMA and other leading health organizations advocate for appropriate patient ID solution

Advocacy Letter

March 24, 2021: MGMA and other health leaders express support for legislation to increase number of Medicare-supported GME positions

Advocacy Statement

March 16, 2021: MGMA statement on Medicare sequester cuts

Advocacy Statement

March 15, 2021: MGMA statement on MedPAC’s Medicare payment policy recommendations

Advocacy Letter

March 12, 2021: MGMA and leading health care advocacy groups urge Congress to prevent Medicare cuts

Advocacy Letter

March 5, 2021: MGMA and other leading health advocacy groups urge CMS to improve MIPS MVPs

Advocacy Letter

March 1, 2021: MGMA submits testimony on "The Future of Telehealth: How COVID-19 is Changing the Delivery of Virtual Care

Advocacy Statement

March 2, 2021: MGMA statement on the Subcommittee on Health of the Committee on Energy and Commerce’s hearing on the future of telehealth

Advocacy Letter

March 1, 2021: MGMA joins coalition urging refinements to Radiation Oncology APM before 2022 start date

Advocacy Letter

Feb. 12, 2021: MGMA joins coalition urging Congress to extend Medicare sequester

Advocacy Letter

Jan. 29, 2021: MGMA letter to House E&C Subcommittee on Oversight & Investigations regarding COVID-19 vaccine hearing

Jan. 27, 2021: MGMA thanks Congress for investing in physician training in Consolidated Appropriations Act, 2021

Advocacy Letter

Jan. 26, 2021: MGMA letter to Biden Administration on inclusion of medical group practices in COVID-19 vaccine distribution strategies

Advocacy Statement

Jan. 15, 2021: MGMA statement on CMS Interoperability and Prior Authorization final rule

Advocacy Letter

Jan. 4, 2021: MGMA comment letter on CMS proposed rule on prior authorization and provider burden

Jan. 4, 2021: MGMA statement on CMS proposed rule on prior authorization

Advocacy Statement

Jan. 4, 2021: MGMA statement on COVID-19 vaccine rollout status

Advocacy Letter

Jan. 4, 2021: MGMA calls on ONC to tie information blocking start date to PHE

Advocacy Statement

December 22, 2020: MGMA statement on Congress’ COVID-19 Stimulus Package

Advocacy Statement

December 18, 2020: MGMA statement on Senate Proposal to Address Prior Authorization

Advocacy Letter

December 14, 2020: MGMA supports congressional effort to mitigate HIPAA fines for practices

December 10, 2020: MGMA statement on the CMS Proposed Rule on Reducing Provider Burden

December 10, 2020: MGMA statement on the Office for Civil Rights HIPAA Proposed Rule

Advocacy Letter

December 3, 2020: MGMA supports Medicare Sequester COVID Moratorium Act

Advocacy Statement

December 1, 2020: MGMA statement on the 2021 Physician Fee Schedule Final Rule

Advocacy Letter

November 27, 2020: MGMA joins effort calling for reevaluation of the CMS Appropriate Use Criteria program

Advocacy Statement

November 23, 2020: MGMA statement on ‘Most Favored Nation’ Interim Final Rule

November 23, 2020: MGMA statement on the Physician Self-referral (Stark) Law and Anti-kickback Statute

Advocacy Letter

November 19, 2020: MGMA and other leading health groups urge Congress to maintain value-based care incentives beyond COVID-19

Advocacy Statement

November 19, 2020: Leading Health Groups Urge Congress to Maintain Value-based Care Incentives Beyond COVID-19

Advocacy Letter

November 7, 2020: MGMA and coalition urge Congress to delay AUC program

Advocacy Statement

November 13, 2020: MGMA asks Congress to extend the moratorium on Medicare sequestration cuts

Advocacy Letter

November 12, 2020: MGMA urges Congress to extend moratorium on Medicare sequestration cuts

Advocacy Letter

November 11, 2020: MGMA joins coalition in support of legislation to prevent Medicare payment cuts in 2021 (HR 8702)

Advocacy Letter

November 10, 2020: MGMA and coalition urge commercial payers to cover supplies necessary to provide safe patient care during COVID-19

Advocacy Letter

November 10, 2020: MGMA and coalition urge CMS to cover supplies necessary to provide safe patient care during COVID-19

Advocacy Statement

November 10, 2020: MGMA statement on the ONC Task Force Report on Prior Authorization

Advocacy Letter

November 5, 2020: MGMA urges CMS to remove deadline to claim missing 2018 APM payments

Advocacy Letter

October 29, 2020: MGMA submits comments to ONC on prior authorization

Advocacy Statement

October 29, 2020: MGMA statement on the ONC interim final rule delaying information blocking requirements until April 5, 2021

Advocacy Statement

October 22, 2020: MGMA poll shows strong opposition to government mandated APMs

Advocacy Letter

October 9, 2020: MGMA joins coalition encouraging legislation to prevent Medicare payment cuts in 2021

Advocacy Letter

October 7, 2020: MGMA joins coalition letter calling for Operating Rules to improve prior authorization

Advocacy Letter

October 2, 2020: MGMA joins coalition urging changes to the final Radiation Oncology Alternative Payment Model

Advocacy Statement

October 1, 2020: MGMA Comments to CMS on Proposed 2021 Physician Fee Schedule

Advocacy Letter

October 1, 2020: MGMA shares comprehensive comments on 2021 Medicare Physician Fee Schedule proposals

Advocacy Letter

September 29, 2020: MGMA calls on ONC to delay enforcement of Information Blocking

Advocacy Letter

September 23, 2020: MGMA urges Senate leaders to support CR and APP modifications

Advocacy Letter

September 23, 2020: MGMA joins coalition to provide comments on proposed 2021 ACO quality changes

Advocacy Letter

August 10, 2020: MGMA submits comments on EHR Reporting Program survey

Advocacy Letter

August 6, 2020: MGMA urges Congress to waive budget neutrality requirements for CY 2021

Advocacy Letter

August 3, 2020: MGMA urges delayed and improved Advance Payment Program repayment conditions

Advocacy Letter

August 3, 2020: MGMA joins coalition to support the Protecting Access to Post-COVID-19 Telehealth Act of 2020

Advocacy Letter

July 30, 2020: MGMA joins coalition urging Congress to lift prohibition on unique patient identifier

Advocacy Letter

July 29, 2020: MGMA joins coalition advocating on surprise billing legislation

Advocacy Statement

July 24, 2020: Press statement on MGMA and coalition supporting the Value in Health Care Act

Advocacy Letter

July 24, 2020: MGMA joins coalition supporting the Value in Health Care Act

Advocacy Letter

July 24, 2020: MGMA Submits Testimony to NCVHS Supporting New Operating Rules to Improve Prior Authorization

Advocacy Letter

July 22, 2020: MGMA urges Senate to include additional assistance for medical groups in next COVID-19 legislation

Advocacy Letter

July 13, 2020: MGMA urges Congress to clarify that PRF payments are nontaxable

Advocacy Letter

July 9, 2020: MGMA joins coalition urging Congress to support the Resident Physician Shortage Reduction Act

Advocacy Letter

July 1, 2020: MGMA joins coalition urging HHS to implement office visit increases and waive budget neutrality

Advocacy Letter

June 30, 2020: MGMA urges HHS to extend public health emergency declaration

Advocacy Letter

June 29, 2020: MGMA joins 340 organizations to ask Congress to extend telehealth flexibilities

Advocacy Letter

June 23, 2020: MGMA joins coalition to ask HHS to continue telehealth waivers

Advocacy Letter

June 17, 2020: MGMA joins coalition urging Congress to extend PPP eligibility to nonprofit organizations in final version of next COVID-19 aid package

Advocacy Letter

June 9, 2020: MGMA joins coalition calling on Congress to include liability protections for physicians in the next COVID-19 relief package

Advocacy Letter

June 3, 2020: MGMA urges Congress to lift prohibition on unique patient identifier

Advocacy Letter

June 2, 2020: MGMA urges HHS to expeditiously disburse unallocated stimulus relief funds to group practices fighting the COVID-19 pandemic

Advocacy Letter

May 22, 2020: MGMA sends letter of support for Senate version of PPP Flexibility Act

Advocacy Letter

May 20, 2020: MGMA sends letter of support for the Paycheck Protection Program Flexibility Act

Advocacy Letter

May 14, 2020: MGMA comments on several provisions of the HEROES Act

Advocacy Letter

May 14, 2020: MGMA joins coalition asking CMS provide additional relief for ACOs

Advocacy Letter

May 6, 2020: MGMA urges SBA to release additional PPP loan forgiveness guidance

Advocacy Letter

April 21, 2020: MGMA asks HHS for clarity on terms and conditions associated with CARES Act Provider Relief funds

Advocacy Letter

April 16, 2020: MGMA asks HHS/CMS to account for providers with low Medicare volumes in next round of CARES Act relief funds

Advocacy Letter

April 15, 2020: MGMA urges Congress to protect the financial viability of group practices

Advocacy Letter

April 10, 2020: MGMA recommends improvements for Medicare's MIPS Value Pathways Program

Advocacy Letter

April 10, 2020: MGMA asks CMS to encourage MA and Part D plans to relax PA and step therapy requirements during COVID

Advocacy Statement

April 14, 2020: MGMA survey sheds light on dire financial impact of COVID-19 on physician practices

Advocacy Statement

April 10, 2020: MGMA statement in response to HHS's initial distribution of $30 billion in grant funds for providers under the CARES Act

Advocacy Letter

April 8, 2020: MGMA joins coalition calling on CMS for E/M payment parity changes and additional telephone E/M guidance for MACs

Advocacy Letter

April 7, 2020: MGMA joins coalition requesting emergency funding for physicians from HHS

Advocacy Letter

April 3, 2020: MGMA submits comments on the 2020-2025 Federal Health IT Strategic Plan

Advocacy Letter

March 27, 2020: MGMA urges HHS to further waive telehealth restrictions following CARES Act

Advocacy Letter

March 27, 2020: MGMA calls on HHS to immediately begin financial support of medical groups

Advocacy Statement

March 27, 2020: MGMA statement on emergency funding for medical practices

Advocacy Letter

March 25, 2020: MGMA joins broad coalition calling on Congress to ensure sustainability of physician practices during COVID-19 emergency

Advocacy Letter

March 20, 2020: MGMA joins coalition calling on Congress to suspend AUC implementation

Advocacy Letter

March 23, 2020: MGMA joins coalition urging Congress to leverage health IT during COVID-19 emergency

Advocacy Letter

March 20, 2020: MGMA joins coalition calling on Congress to ensure sustainability of physician practices during COVID-19 emergency

Advocacy Letter

March 18, 2020: MGMA joins coalition calling on House to ensure access to Medicare value based care during COVID-19 pandemic

Advocacy Letter

March 18, 2020: MGMA joins coalition calling on CMS to allow flexibilities for QPP-participating clinicians

Advocacy Letter

March 18, 2020: MGMA joins coalition calling on Senate to ensure access to Medicare value based care during COVID-19 pandemic

Advocacy Letter

March 18, 2020: MGMA urges Congress to provide direct financial assistance to group practices and take further action on COVID-19

Advocacy Letter

March 11, 2020: MGMA urges HHS to exercise telehealth waiver authority

Advocacy Statement

March 9, 2020: MGMA statement on ONC and CMS interoperability rules

Advocacy Letter

March 2, 2020: MGMA submits comments to CMS on Medicare Advantage Star Rating Program

Advocacy Letter

Feb. 13, 2020: MGMA letter of support for the Consumer Protections Against Surprise Medical Bills Act of 2020

Advocacy Letter

Jan. 31, 2019: MGMA and others urge gradual timeline for removal of MIPS measures

Advocacy Statement

January 21, 2020: MGMA alarmed by new evidence of increasing prior authorization costs for physician practices

Advocacy Letter

Jan. 6, 2020: MGMA joins others to urge passage of Social Determinants Accelerator Act

Advocacy Letter

Dec. 30, 2019: MGMA urges OIG to modernize and clarify the Anti-kickback Statute

Advocacy Letter

Dec. 19, 2019: MGMA urges CMS to modernize and clarify the Stark Law

Advocacy Letter

Dec. 16, 2019: MGMA submits letter to Representatives DeGette and Upton on CURES 2.0

Advocacy Letter

Dec. 9, 2019: MGMA signs on to letter to CMS urging improved patient matching

Advocacy Letter

Dec. 9, 2019: MGMA opposes 45 day billing provision in healthcare legislation

Advocacy Letter

Dec. 4, 2019: MGMA joins coalition supporting Opioid Workforce Act

Advocacy Letter

November 20, 2019: MGMA submits comments to CMS on prior authorization

Advocacy Letter

October 30, 2019: MGMA commends Congress for introduction of bicameral, bipartisan legislation to expand telehealth services to Medicare beneficiaries

Advocacy Letter

October 25, 2019: MGMA submits comments to SAMHSA on substance abuse records proposed rule

Advocacy Letter

October 22, 2019: MGMA joins coalition supporting Rural ACO Improvement Act

Advocacy Letter

October 16, 2019: MGMA and others share concerns with Congress about current surprise billing proposals

Advocacy Statement

October 14, 2019: MGMA survey finds significant increase in regulatory burden on medical practices

Advocacy Statement

October 9, 2019: MGMA statement on CMS' proposed Physician Self-Referral (Stark) rule

Advocacy Statement

September 25, 2019: MGMA statement on CMS proposed physician fee schedule & QPP

Advocacy Statement

September 23, 2019: MGMA Statement on Concerns Regarding ONC's Implementation of 21st Century Cures Act

Advocacy Letter

September 20, 2019: MGMA shares comprehensive comments on 2020 Medicare Physician Fee Schedule proposals

Advocacy Letter

September 23, 2019: MGMA calls on Congress to continue oversight of ONC Cures Act implementation

Advocacy Letter

September 19, 2019: MGMA and 100+ organizations urge comprehensive prior authorization reform

Advocacy Letter

September 16, 2019: MGMA urges CMS to release advanced APM funds

Advocacy Letter

September 9, 2019: MGMA joins 370 stakeholders calling for prior authorization reform

Advocacy Letter

August 27, 2019: MGMA advocates for appropriate patient identification solutions

Advocacy Letter

August 15, 2019: MGMA Responds to Proposed Electronic Prior Authorization Standard

Advocacy Statement

August 12, 2019: MGMA Statement on Patients over Paperwork RFI

Advocacy Letter

August 13, 2019: MGMA Responds to Proposed Section 1557 Revisions

Advocacy Letter

August 12, 2019: MGMA's Response to Patients Over Paperwork RFI

Advocacy Letter

July 16, 2019: MGMA sign-on letter to the Energy and Commerce Committee regarding the No Surprises Act

Advocacy Letter

July 10, 2019: MGMA sends letter to Energy and Commerce Committee in response to No Surprises Act

Advocacy Letter

June 26, 2019: MGMA signs on to letter supporting Opioid Workforce Act

Advocacy Letter

June 25, 2019: MGMA letter supporting legislation removing CCM cost-sharing

Advocacy Letter

June 25, 2019: MGMA response to Senate HELP plan to lower health care costs

Advocacy Letter

June 11, 2019: MGMA letter urging support of the Foster-Kelly amendment to HR 2740

Advocacy Letter

June 5, 2019: MGMA response to Senate HELP Committee's Lower Health Care Costs Act discussion draft

Advocacy Letter

June 5, 2019: MGMA supports prior authorization legislation for MA plans

Advocacy Statement

June 5, 2019: MGMA applauds new prior authorization bill

Advocacy Letter

June 3, 2019: MGMA urges Congress to improve MACRA

Advocacy Letter

June 3, 2019: MGMA and coalition send Patient Matching letter to Congressional leadership

Advocacy Letter

June 3, 2019: MGMA and coalition send letter on 21st Century Cures Act

Advocacy Letter

May 30, 2019: MGMA sends letter to HHS on Next Gen ACOs

Advocacy Statement

May 30, 2019: MGMA supports Administration’s interoperability goals, cautions against added cost, complexity, security risks

Advocacy Letter

May 30, 2019: MGMA provides feedback to CMS regarding the Direct Contracting Geographic Population-based Payment model

Advocacy Letter

May 30, 2019: MGMA submits comments on CMS proposed rule on interoperability

Advocacy Letter

May 30, 2019: MGMA submits comments on ONC proposed rule on interoperability, information blocking, and health IT certification program

Advocacy Statement

MGMA 2019 Advocacy Agenda

Advocacy Letter

5/20/2019: MGMA letter on unexpected medical bills

Advocacy Statement

May 8, 2019: MGMA statement before the U.S. Senate Committee on Finance

Advocacy Letter

May 7, 2019: MGMA sends letter in support of the Safe Step Act of 2019 (H.R. 2279)

Advocacy Letter

April 23, 2019: MGMA joins in opposing H.R. 2143, the "Promoting Integrity in Medicare Act"

Advocacy Letter

April 10, 2019: MGMA and other leading healthcare organizations convey support to the House for the Medicare Care Coordination Act of 2019

Advocacy Letter

April 10, 2019: MGMA and GME coalition send letter in support of the Resident Physician Shortage Reduction Act

Advocacy Letter

April 2, 2019: MGMA and leading healthcare organizations convey support to the Senate for the Medicare Care Coordination Improvement Act of 2019

Advocacy Letter

April 1, 2019: MGMA outlines surprise billing policy framework to Congressional leadership

Advocacy Letter

April 1, 2019: MGMA responds to the Congressional Telehealth Caucus's Request for Information on expanding access to telehealth services

Advocacy Letter

March 26, 2019: MGMA joins coalition calling for Improving Transparency for Innovation Center Models

Advocacy Letter

February 28, 2019: MGMA calls on CMS to address prior authorization use by MA plans

February 7, 2019: MGMA joins stakeholder group sharing concerns on surprise billing

Advocacy Letter

February 12, 2019: MGMA responds to OCR RFI on modifying HIPAA rules

Advocacy Letter

January 28, 2019: MGMA comments in response to ONC publication of "Strategy on Reducing Regulatory and Administrative Burden Relating to the Use of Health IT and EHRs"

Advocacy Letter

January 18, 2019: MGMA and healthcare coalition call on CMS to delay MSSP ACO application deadline

Advocacy Letter

December 6, 2018: MGMA comments on the National Committee on Vital and Health Statistics "Draft Recommendations for the Predictability Roadmap"

Advocacy Letter

Dec. 3, 2018: MGMA and other physician organizations provide feedback to CMS on Open Payments Program educational materials

Advocacy Statement

November 1, 2018: MGMA statement on 2019 Medicare Physician Fee Schedule Final Rule

Advocacy Letter

October 26, 2018: MGMA responds to OIG request for information on the Anti-Kickback Statute

Advocacy Letter

October 17, 2018: MGMA comments on ONC RFI on the CURES Act

Advocacy Letter

October 16, 2018: MGMA submits comments on MSSP proposed rule

Advocacy Letter

September 20, 2018: MGMA and Stakeholder Group Send CMS Letter of Support for ACOs and MSSP

Advocacy Statement

September 20, 2018: MGMA and stakeholder group urge CMS to ensure continued success of ACO program

Advocacy Statement

September 11, 2018: 28 Physician Groups Ask Congress for AUC Program Relief

Advocacy Letter

September 7, 2018: MGMA joins physician organizations opposing step therapy in Medicare Advantage

Advocacy Letter

September 7, 2018: MGMA shares comprehensive comments on Medicare Physician Fee Schedule proposals

Advocacy Letter

September 7, 2018: Physician Groups Ask Congress for AUC Program Relief

Advocacy Letter

September 6, 2018: MGMA commends Congressional efforts to advance regulatory relief initiative

Advocacy Letter

August 27th, 2018: MGMA and coalition of healthcare organizations send CMS a letter on proposed E/M changes

Advocacy Letter

August 24, 2018: MGMA responds to CMS Physician Self-Referral Law Request for Information

Advocacy Letter

August 1, 2018: MGMA joins coalition of healthcare organizations urging Congress to remove barriers to value-based care

Advocacy Letter

July 16, 2018: MGMA comments in response to HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

Advocacy Statement

July 12, 2018: MGMA statement on Release of Physician Fee Schedule Proposed Rule

Advocacy Letter

June 21, 2018: MGMA comments on 2019 IPPS proposed rule

Advocacy Letter

June 25, 2018: Medical Association Coalition response to 2019 IPPS proposed final rule

Advocacy Letter

June 1, 2018: MGMA and a coalition of other leading healthcare organizations send letter to the head of CMMI on APM participation criteria

Advocacy Statement

May 24, 2018: MGMA outlines physician group practice priorities in CMS’ proposed direct contracting model

Advocacy Letter

May 24, 2018: MGMA comments in response to the Center for Medicare and Medicaid Innovation Request for Information on Direct Provider Contracting Models

Advocacy Letter

May 23rd, 2018: MGMA calls on CMS to enforce health plan HIPAA compliance

Advocacy Statement

May 23, 2018: MGMA statement on passage of the VA Maintaining Internal Systems and Strengthening Integrated Outside Networks (VA MISSION) Act of 2018

Advocacy Letter

May 9, 2018: MGMA and other leading healthcare organizations urge Congress to end patient safety issues related to patient matching

Advocacy Letter

April 16, 2018: An urge for CMS to reduce 2018 MIPS reporting period

Advocacy Letter

April 2, 2018: Urging an end electronic payments abuses

Advocacy Statement

March 22, 2018: MGMA statement for Ways and Means MACRA implementation hearing

Advocacy Letter

March 15, 2018: MGMA Responds to Ways and Means RFI on opioid epidemic

Advocacy Statement

March 15, 2018: MGMA statement on Ways and Means Medicare Red Tape Relief Initiative

Advocacy Statement

March 15, 2018: MGMA comment on the MedPAC March 2018 report to Congress

Advocacy Statement

March 1, 2018: MGMA Poll: Medical group practices oppose mandatory Medicare alternative payment models

Advocacy Letter

February 13, 2018: CMS responds to MGMA concerns of MIPS vital information missing

Advocacy Letter

February 22, 2018: MGMA to CMS: Allow ACOs three more years in Track 1

Advocacy Letter

February 2, 2018: MGMA comments on ONC draft Trusted Exchange Framework

Advocacy Letter

February 7, 2018: MGMA administrative burdens letter

Advocacy Letter

January 1, 2018: Consensus Statement on Improving the Prior Authorization Process

Advocacy Letter

January 1, 2018: MGMA comments on proposed 2019 Medicare Advantage, Part D plan changes

Advocacy Letter

January 1, 2018: MGMA to CMS: Immediately release 2018 MIPS eligibility notices

Advocacy Letter

December 13, 2017: MGMA sends letter to Congressional leadership to oppose sequestration cuts to Medicare

Advocacy Letter

November 20, 2017: MGMA response to episode-based cost measures

Advocacy Letter

November 20, 2017: MGMA comments in response to RFI on CMMI's new direction

Advocacy Letter

November 1, 2017: MGMA supports Medicare Care Coordination Improvement Act

Advocacy Letter

November 1, 2017: MGMA supports Medicare Care Coordination Improvement Act

Advocacy Letter

October 23, 2017: MGMA letter to CMS expressing concern about the Clinical Laboratory Fee Schedule (CLFS)

Advocacy Letter

October 16, 2017: MGMA letter to Congressional leadership on CSR payments and marketplace stabilization

Advocacy Letter

October 2, 2017: MACRA letter on CMS flexibility with QPP

Advocacy Letter

September 22, 2017: MGMA letter on Graham-Cassidy Amendment

Advocacy Letter

September 11, 2017: MGMA 2018 CMS Physician Fee Schedule Comment Letter

Advocacy Letter

September 8, 2017: MGMA to CMS: New laboratory payment initiatives could sideline POLs

Advocacy Letter

August 25, 2017: MGMA sends Appendix I Committee Letter

Advocacy Letter

August 21, 2017: MGMA submits comments in response to proposed 2018 Quality Payment Program rule

Advocacy Letter

July 26, 2017: Coalition calls for electronic attachment standards

Advocacy Letter

June 27, 2017: MGMA comments on Better Care Reconciliation Act

Advocacy Letter

June 21, 2017: Track 1+ repayment mechanism letter

Advocacy Letter

June 13, 2017: MGMA IPPS Proposed Rule comment letter

Advocacy Letter

May 31, 2017: MGMA MACRA Medicare Advantage sign-on letter

Advocacy Letter

May 11, 2017: MGMA SSNRI letter to CMS

Advocacy Letter

May 10, 2017: CONNECT for Health Act letter

Advocacy Letter

April 24, 2017: MGMA QPP cost measures comment letter

Advocacy Letter

April 5, 2017: MGMA Labor-H patient matching support letter

Advocacy Letter

March 30, 2017: PAMA sign-on letter

Advocacy Letter

March 22, 2017: MGMA letter commenting on the American Health Care Act of 2017

Advocacy Letter

March 31, 2017: MGMA signs on to letter to CMS regarding Medicare value-based purchasing program penalties

Advocacy Letter

March 15, 2017: MGMA letter to CMS Administrator Verma

Advocacy Letter

March 7, 2017: MGMA comments to FCC on practice use of patient-supplied telephone numbers

Advocacy Letter

February 27, 2017: MGMA signs on to letter to CMS and ONC regarding 2015 CEHRT

Advocacy Letter

February 27, 2017: Letter to CMS and ONC regarding 2015 CEHRT

Advocacy Letter

February 10, 2017: MGMA letter to HHS Secretary Price

Advocacy Statement

January 17, 2018: MGMA statement following the bipartisan Senate Finance committee vote to advance the nomination of Alex Azar for HHS Secretary

Advocacy Letter

December 15, 2016: MGMA comments on the development of a new Medicare ACO model, Track 1 Plus (1+)

Advocacy Letter

August 20, 2016: Joint letter to CMS on removing social security numbers from Medicare ID cards

Advocacy Letter

April 25, 2016: Letter to CMS on provider enrollment process

Advocacy Letter

November 17, 2015: MGMA comments on MACRA RFI